Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of pimecrolimus and microneedling in vitiligo
IRCT20190521043664N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pimecrolimus in Vitiligo (2 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2019; status: completed.
02
Drugs
pimecrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20190521043664N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190521043664N1.